Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine | Zendy

Zheng Quan Toh | Zendy; Kathleen Wen Bei Cheow | Zendy; Fiona M. Russell | Zendy; Edwin Hoe | Zendy; Rita Reyburn | Zendy; James Fong | Zendy; Evelyn Tuivaga | Zendy; Felisita Tupou Ratu | Zendy; Cattram Nguyen | Zendy; Silivia Matanitobua | Zendy; Andrea Reitsma | Zendy; Sepehr N. Tabrizi | Zendy; Suzanne M. Garland | Zendy; Kim Mulholland | Zendy; Paul V. Licciardi | Zendy

Open Access

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine

Author(s) -

Zheng Quan Toh,

Kathleen Wen Bei Cheow,

Fiona M. Russell,

Edwin Hoe,

Rita Reyburn,

James Fong,

Evelyn Tuivaga,

Felisita Tupou Ratu,

Cattram Nguyen,

Silivia Matanitobua,

Andrea Reitsma,

Sepehr N. Tabrizi,

Suzanne M. Garland,

Kim Mulholland,

Paul V. Licciardi

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy147

Subject(s) - medicine , elispot , immune system , immunology , cellular immunity , vaccination , peripheral blood mononuclear cell , immunity , cohort , physiology , t cell , biology , biochemistry , in vitro

These data suggest that cellular immunity following reduced-dose schedules was detectable after 6 years, although the responses were variable between HPV types and dosage groups. The clinical significance of this is unknown. Further studies on the impact of reduced dose schedules are needed, particularly in high-disease burden settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research